Montelukast

Back to search

Molecule Structure

Scientific Name

Montelukast

Description of the Drug

Montelukast is a leukotriene receptor antagonist used as part of an asthma therapy regimen, to prevent exercise induced bronchoconstriction, and to treat seasonal allergic rhinitis.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00471

Brand Name(s)

Singulair

Company Owner(s)

Cipla Ltd, Unimark Remedies Ltd, Jubilant Generics Ltd, Macleods Pharmaceuticals Ltd, Mylan Pharmaceuticals Inc, Amneal Pharmaceuticals Of New York Llc, Torrent Pharmaceuticals Ltd, Apotex Corp, Ajanta Pharma Ltd, Anbison Laboratory Co Ltd

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Cysteinyl leukotriene receptor 1 SINGLE PROTEIN ANTAGONIST CHEMBL1798

Unichem Links

SureChEMBL SCHEMBL4486
PharmGKB PA450546
Human Metabolome Database HMDB0014614
DrugBank DB00471
PubChem: Thomson Pharma 14886896 14886895
PubChem 5281040
LINCS LSM-43228
Nikkaji J870.100H J2.625.694A
PDBe MTK
BindingDB 50052024
EPA CompTox Dashboard DTXSID9023334
DrugCentral 1836
ChemicalBook CB7112818
Guide to Pharmacology 3340
rxnorm MONTELUKAST SODIUM MONTELUKAST SINGULAIR
KEGG Ligand C07482
ChEBI 50730
ZINC ZINC000003831151